Martin Peterka is a genome engineering scientist at AstraZeneca, focusing on the development of advanced targeted genome editing technologies, particularly CRISPR prime editing for therapeutic uses. With over 10 years of research experience in both academia and the pharmaceutical industry, Martin previously held positions as a PhD candidate at ETH Zürich and as a postdoctoral researcher specializing in genome engineering. Martin's educational background includes a Doctor of Philosophy (PhD) in Cell/Cellular and Molecular Biology from ETH Zürich and is currently pursuing a Master of Science (MSc) in the same field at Charles University in Prague.
This person is not in the org chart
This person is not in any teams
This person is not in any offices